Coherus Oncology (CHRS) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order virtually, with stockholders attending via a web portal and rules of conduct provided for orderly proceedings.

• The agenda included five proposals: election of directors, ratification of the auditor, advisory vote on executive compensation, increase in equity plan shares, and a proposal on stock option exercise price reduction.

Board and executive committee updates

• Two Class III directors, Dennis M. Lanfear and Mats L. Wahlström, were nominated to serve until the 2029 Annual Meeting.

• No advance notice of alternative director nominations was received from stockholders.

Shareholder proposals

• Proposals included electing directors, ratifying the auditor, approving executive compensation, and increasing shares under the equity plan.

• The proposal to reduce the exercise price of certain stock options was adjourned to a later date to ensure all votes are counted.